Fintel reports that on January 13, 2025, D. Boral Capital initiated coverage of Checkpoint Therapeutics (NasdaqCM:CKPT) with a Buy recommendation. As of December 23, 2024, the average one-year price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback